Here are five notes:
1. Amedica’s device is a composite spinal fusion implant featuring various densities of the company’s proprietary medical grade silicon nitride ceramic.
2. The company manufactured a silicon nitride shell around a porous core, Cancellous structured Ceramic.
3. The CASCADE clinical trial found CsC is able to achieve s spinal fusion without added bone grafts. Additionally, CsC has success rates in line with bone autograft.
4. The Valeo C+CsC with Lumen Interbody Fusion Device is designed for cervical intervertebral body fusion.
5. The device is already approved in Europe.
More articles on surface technology:
Stryker receives FDA clearance for 3-D printed tritanium lumbar cage: 5 notes
Why spinal implant surface technology makes a difference: 2 key thoughts from Dr. Raphael Rey Roybal
Spineology receives notice of allowance for PEEK, titanium and graft containment mesh implant system: 4 highlights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
